PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
22542771-10	2012	The present study showed that treatment with exenatide significantly inhibited cytochrome c release and decreased the intracellular expression levels of Bax and caspase-3, whereas Bcl-2 was increased (P<0.05).	Exenatide	45-54	B cell leukemia/lymphoma 2	Mus musculus	180-185	
30885636-9	2019	Western blot and RT-PCR were performed to detect the effect of exenatide on apoptosis-related genes (Bcl-2 and Bax) and inflammation-related genes and/or proteins (tumour necrosis factor-alpha, interleukin-6, nuclear factor-kappaB, and p53).	Exenatide	63-72	B cell leukemia/lymphoma 2	Mus musculus	101-106	
22727809-9	2012	Exenatide protects RGC-5 from high- or low-glucose-induced Bax increased and Bcl-2 decreased.	Exenatide	0-9	B cell leukemia/lymphoma 2	Mus musculus	77-82